EX-16.1 11 d285643dex161.htm EX-16.1 EX-16.1

Exhibit 16.1

July 15, 2022

Office of the Chief Accountant

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read the statements made by ProKidney Corp. under Item 4.01 of its Form 8-K dated July 15, 2022. We agree with the statements concerning our Firm under Item 4.01. We are not in a position to agree or disagree with other statements contained therein.

Very truly yours,

/s/ Marcum LLP

Marcum LLP

New York, NY